Why the study?
Does screening and treatment of preoperative anemia reduce costs, ABT, LOS, and complications in patients undergoing elective major orthopedic surgery?
Does screening and treatment of preoperative anemia reduce costs, ABT, LOS, and complications in patients undergoing elective major orthopedic surgery?
Screening and treating preoperative anemia in major orthopedic surgery may reduce costs, blood transfusions, length of stay, and complications.
Answers are grounded in this paper and cite their sources.
May support POA screening to reduce costs and transfusions in elective orthopedic surgery; leaves open confirmation of outcomes in RCTs.
The prevalence of POA in elective orthopedic surgery in Sweden is at the same level as previously reported by others. Screening and treatment of POA would reduce costs based on less ABT and decreased LOS and may reduce complications in elective major orthopedic surgery.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: